ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 127 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $13,086,000 | -51.5% | 900,000 | -40.0% | 0.78% | -29.1% |
| Q3 2021 | $27,000,000 | -23.1% | 1,500,000 | -25.0% | 1.10% | -8.0% |
| Q2 2021 | $35,120,000 | -30.3% | 2,000,000 | 0.0% | 1.19% | +6.2% |
| Q1 2021 | $50,400,000 | +18566.7% | 2,000,000 | +700.0% | 1.12% | +6918.8% |
| Q3 2019 | $270,000 | -50.7% | 250,000 | 0.0% | 0.02% | -48.4% |
| Q2 2019 | $548,000 | -78.2% | 250,000 | -40.6% | 0.03% | -81.8% |
| Q1 2019 | $2,519,000 | -28.7% | 420,555 | -12.0% | 0.17% | -40.8% |
| Q4 2018 | $3,533,000 | -51.3% | 478,055 | -4.4% | 0.29% | -39.2% |
| Q3 2018 | $7,260,000 | -30.8% | 500,000 | -4.9% | 0.47% | -39.3% |
| Q2 2018 | $10,495,000 | +14.0% | 525,538 | 0.0% | 0.78% | +13.3% |
| Q1 2018 | $9,207,000 | -32.1% | 525,538 | -4.4% | 0.69% | -51.7% |
| Q4 2017 | $13,563,000 | -4.5% | 550,000 | 0.0% | 1.42% | -43.4% |
| Q3 2017 | $14,196,000 | -27.3% | 550,000 | -23.6% | 2.51% | -22.6% |
| Q2 2017 | $19,526,000 | -18.2% | 720,000 | -10.0% | 3.24% | -6.6% |
| Q1 2017 | $23,856,000 | -10.0% | 800,000 | -18.1% | 3.46% | -3.0% |
| Q4 2016 | $26,496,000 | +14.8% | 976,286 | +8.3% | 3.57% | +40.4% |
| Q3 2016 | $23,082,000 | +38.7% | 901,286 | 0.0% | 2.54% | +7.8% |
| Q2 2016 | $16,647,000 | +35.6% | 901,286 | +39.1% | 2.36% | +27.6% |
| Q1 2016 | $12,279,000 | -29.7% | 647,944 | 0.0% | 1.85% | -11.4% |
| Q4 2015 | $17,456,000 | – | 647,944 | – | 2.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |